N/A N=47 Integrative Medicine Consultation for Patients With Pain or Fatigue
Pain · Fatigue
Primary: Short Form 36 (SF-36) Physical Component Summary (PCS) — 36.2; 39.0 Scores on a scale — p=0.487
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=50,458 Primary Palliative Care for Emergency Medicine (PRIM-ER)
Emergencies
Primary: Acute Care Admission — 0.644; 0.613 Proportion of participants
Phase 2 N=405 Development of Rational Ways of Medical and Non-medical Treatment Methods for Metabolic Syndrome
Metabolic Syndrome
Primary: Blood Glucose Level — 6.05; 6.43; 4.58; 14.5 mmole/L
N/A N=159 Food Insecurity, Food as Medicine, Hypertension
Food Insecurity · Hypertension
Primary: Change Systolic Blood Pressure — 9.39; .25 mmHg
N/A N=33 Improving Medical Training for the Care of Chronic Conditions
Diabetes Mellitus
Primary: Change in Confidence in Ability to Perform Teamwork — 1.40; -0.12 units of a scale — p=0.04
N/A N=52 The Medication Metronome Project - Study to Facilitate Follow-up Testing Resulting From Prescribed Medications to Improve Patient Safety and Care
Diabetes Mellitus, Type 2 · Hypertension · Hyperlipidemia
Primary: Primary Effectiveness Outcome - LDL — 57.9; 54.8 percentage of time spent at goal
N/A N=1,606 Emergency Medicine Palliative Care Access
Advanced Cancer · End Stage Organ Failure
Primary: Change in Quality of Life for Patients, as Measured by the Functional Assessment of Cancer Therapy - General (FACT-G) — 3.7; 3.1 score on a scale
N/A N=655 Point of Care Ultrasound Use by General Practitioners in France (Echo-MG)
Point of Care Ultrasound
Primary: Number of Patients With Change in the Diagnosis After POCUS Examination — 397 Participants
N/A N=109 Trial of Simulation-based Mastery Learning to Communicate Diagnostic Uncertainty
Uncertainty · Communication Research · Emergency Medicine
Primary: % of Residents Who Pass the UCC at the T2 Assessment — 29; 2 Participants
Phase 3 N=192 Clinical Investigation Using MED3000 Gel or Tadalafil Tablets in the Treatment of Erectile Dysfunction
Erectile Dysfunction
Primary: Change From Baseline in the Erectile Function (EF) Domain of the International Index of Erectile Function (IIEF) Questionnaire, in Patients Randomised to MED3000, at…
N/A N=171 Medical Arm of the Interagency Registry for Mechanically Assisted Circulatory Support
Heart Failure · Systolic Heart Failure
Primary: Number of Heart Failure Participants Deceased at 24 Months — 43 Participants
N/A N=920 Northwestern University and Access Community Health Network Medication Education Study
Hypertension
Primary: Systolic Blood Pressure — 134.5; 141.7; 134.6 mm Hg
N/A N=159 Integrative Medicine Group Visits: A Patient-Centered Approach to Reducing Chronic Pain and Depression
Chronic Pain · Depression
Primary: Chronic Pain — 6.0; 6.0; 6.0; 5.0 units on a scale — p=0.68
N/A N=170 Real World Data on Management of Male LUTS
Benign Prostatic Hyperplasia
Primary: The Percentage of Men Given a Drug Prescription for Their Urinary Symptoms, as Recorded in Their Medical Records — 35.7 Percentage of participants
N/A N=28 Behavioral Medicine Intervention With Depressed Patients in a Community Health Center Setting
Depression
Primary: Depression Severity (CEDS-10) — 18; 12 units on a scale — p=<.001
N/A N=89 Nourishing the Community Through Culinary Medicine - Acres Homes
Diabetes · Elevated Body Mass Index
Primary: Hemoglobin A1c (HbA1c) Level — 8.40; 8.80; 7.60; 8.25 mmol/mol
N/A N=102 Medication Adherence in Rheumatic Diseases
Chronic Rheumatic Diseases
Primary: Intervention Feasibility as Measured by Number of Providers Agreeing to Participate — 6 Participants
N/A N=24 MIDAS Cluster Randomized Controlled Trial of Implementation Strategies to Optimize Use of Medications in VA Clinical Settings
Polypharmacy · Insomnia · Anticoagulants
Primary: Change in the Percentage of Patients With Potentially Inappropriate Medication Use (PIMs) Between Pre- and Post-periods, Across Facilities. — -0.133; -0.395 percentage…
Phase 3 N=40 Patient Computer Dialog in Primary Care
Patient Computer Dialog
Primary: Patient Post Medical History Assessment Questionnaire — 8.4; 8.3 units on a scale
N/A N=155 Study of Medical Student Use of Templates to Document Outpatient Asthma Care in Electronic Medical Record
Disease
Primary: Number of Participants Using Evidence-based Template to Document Asthma Care Within an Electronic Medical Record — 41; 11 participants — p=.01
N/A N=44 Cirrhosis Medical Home
Cirrhosis, Liver
Primary: Enrollment Rate — 20; 20 Participants
N/A N=250 Pharmacist-led Group Medical Visits to Help With Diabetes Management
Diabetes Mellitus · Cardiovascular Diseases
Primary: Hemoglobin A1c — 7.8; 8.1 percent Hemoglobin A1c
Phase 1 N=24 A Study to Learn About the Study Medicine (PF-07293893) at Different Dose Levels in Healthy Adults
Healthy Participants
Primary: Number of Participants With Treatment Emergent Adverse Events (TEAEs) — 1; 2; 1; 2 Participants
N/A N=2,780 Realtime Streaming Clinical Use Engine for Medical Escalation
Clinical Deterioration · Hospital Medicine · Monitoring, Physiologic
Primary: Overall Rate of Escalation — 12.3; 11.3 escalations per 1,000 patient bed days — p=< 0.001
N/A N=40 Heart Failure Medication Adherence
Heart Failure
Primary: Adherence to Medication — 2; 3 Participants
N/A N=75 Pharmacogenomic Testing in Primary Care
Antidepressants Causing Adverse Effects in Therapeutic Use
Primary: Count of Participants Prescribed Antidepressant Medication — 5; 8; 5; 8 Participants
N/A N=826 MedStar Diabetes Pathway Chart Reviews
Type2 Diabetes Mellitus
Primary: Percent Change in A1C — -3.06; -1.44 % change — p=<0.001
N/A N=80 A Study To Assess Safety And Effectiveness Of Medrol In Contact Dermatitis In Indian Patients
Dermatitis, Contact
Primary: Treatment Status (Success/Failure) of Contact Dermatitis (CD) at the Second Follow-up Visit — 93.8; 6.30 Percentage of Participants
Phase 1 N=44 Safety and Tolerability of MEDI9314 as Single Ascending Dose in Healthy Subjects
Safety · Healthy Subjects
Primary: Number of Participants With Treatment-emergent Adverse Events (TEAEs) and Treatment-emergent Serious Adverse Events (TESAEs) — 8; 4; 2; 5 Participants
N/A N=5,421 Medication Adherence Clinical Decision Support
Hyperlipidemia · Hypertension · Diabetes
Primary: Blood Pressure Medication Adherence — 396; 470 Participants — p=0.0103